UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ACE polymorphisms and COVID-19-related mortality in Europe

Journal of molecular medicine (Berlin, Germany), 2020-11, Vol.98 (11), p.1505-1509

2020

Volltextzugriff (PDF)

Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer

Frontiers in immunology, 2020-11, Vol.11, p.565470-565470

2020

Volltextzugriff (PDF)

Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy

Clinical cancer research, 2018-05, Vol.24 (9), p.2171-2181

2018

Volltextzugriff (PDF)

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

Nature communications, 2018-12, Vol.9 (1), p.4832-13, Article 4832

2018

Volltextzugriff (PDF)

Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization

Cancer research (Chicago, Ill.), 2018-05, Vol.78 (10), p.2654-2668

2018

Volltextzugriff (PDF)

Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma

Frontiers in immunology, 2018-07, Vol.9, p.1786-1786

2018

Volltextzugriff (PDF)

Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression

Cell reports (Cambridge), 2018-03, Vol.22 (11), p.3006-3020

2018

Volltextzugriff (PDF)

The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma

Frontiers in immunology, 2022-03, Vol.13, p.845422-845422

2022

Volltextzugriff (PDF)

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors

Oncoimmunology, 2013-01, Vol.2 (1), p.22-21

2013

Volltextzugriff (PDF)

Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis

Frontiers in immunology, 2020-09, Vol.11, p.1820

2020

Volltextzugriff (PDF)

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?

Neoplasia (New York, N.Y.), 2019-01, Vol.21 (1), p.93-105

2019

Volltextzugriff (PDF)

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (3), p.658-671

2017

Volltextzugriff (PDF)

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma

Frontiers in oncology, 2021-10, Vol.11, p.760732-760732

2021

Volltextzugriff (PDF)

iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells

PloS one, 2010-01, Vol.5 (1), p.e8646-e8646

2010

Volltextzugriff (PDF)

A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer

Cancer biology & medicine, 2021-05, Vol.18 (2), p.604-615

2021

Volltextzugriff (PDF)

Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-β

Molecular cancer therapeutics, 2017-02, Vol.16 (2), p.365-375

2017

Volltextzugriff (PDF)

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy

Cancer Immunology, Immunotherapy, 2020-06, Vol.69 (6), p.1141-1151

2020

Volltextzugriff (PDF)

Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

Microbiology and molecular biology reviews, 2020-06, Vol.84 (2)

2020

Volltextzugriff (PDF)

Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.201-201, Article 201

2019

Volltextzugriff (PDF)

Modulators of arginine metabolism support cancer immunosurveillance

BMC immunology, 2009-01, Vol.10 (1), p.1-1, Article 1

2009

Volltextzugriff (PDF)

Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method

EJNMMI radiopharmacy and chemistry, 2024-06, Vol.9 (1), p.50-30, Article 50

2024

Volltextzugriff (PDF)

Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer

Cytokine & growth factor reviews, 2017-08, Vol.36, p.17-24

2017

Volltextzugriff (PDF)

Won't you come on in? How to favor lymphocyte infiltration in tumors

Oncoimmunology, 2012-09, Vol.1 (6), p.986-988

2012

Volltextzugriff (PDF)

A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma

Oncoimmunology, 2014-11, Vol.3 (11), p.e963406-e963406

2014

Volltextzugriff (PDF)

Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers

European urology oncology, 2023-06, Vol.6 (3), p.273-274

2023

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

ACE polymorphisms and COVID-19-related mortality in Europe

Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer

Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization

Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma

Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression

The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors

Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma

iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells

A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer

Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-β

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy

Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival

Modulators of arginine metabolism support cancer immunosurveillance

Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method

Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer

Won't you come on in? How to favor lymphocyte infiltration in tumors

A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma

Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers

Suchergebnisse filtern